| Abilify Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Abilify 20 mg | tablet | oral | 1.0 each | OTC |
| Abilify 5 mg | tablet | oral | 1.0 each | OTC |
| Abilify 30 mg | tablet | oral | 1.0 each | OTC |
| Abilify 10 mg | tablet | oral | 1.0 each | OTC |
| Abilify 2 mg | tablet | oral | 1.0 each | OTC |
| Abilify 15 mg | tablet | oral | 1.0 each | OTC |
| Abilify 1 mg/mL | solution | oral | 1.0 milliliter(s) | OTC |
| Abilify 7.5 mg/mL | solution | intramuscular | 1.0 milliliter(s) | OTC |
Posted by mamahen 13 days ago
OH MY GOD!!!
I have been taking Abilify for one week, and the most scary thing happened to me last night....I woke up becaus...
Posted by embarrassed 17 days ago
So embarrassing, but I have to warn people. I started taking abilify 2 years ago and right away I experienced bed wetting......
Posted by catmenrulz 2 months ago
I got taken off of abilify the very day I started. The doctor prescribed 2mg and the 5mg later if it worked out. I am thankin...
FDA OKs Abilify for Children - FDA news (subscription)
The FDA has approved a supplemental new drug application submitted by Otsuka Pharmaceutical and Bristol-Myers Squibb (BMS) for Abilify to treat manic and ...
Tue Mar 04 17:36:44 -0500 2008
ABILIFY Now Available for Younger Patients with Bipolar Disorder - MedHeadlines
ABILIFY (aripiprazole) has been approved by the FDA for patients 10 to 17 years old for the treatment of acute manic and mixed episodes of Bipolar I ...
Mon Mar 03 22:46:16 -0500 2008
FDA OKs Abilify for Children - FDA news (subscription)
all 2 news articles
Tue Mar 04 17:36:44 -0500 2008
aripiprazole - A quinoline derivate and atypical anti-psychotic agent. Aripiprazole has partial agonistic activity at dopamine D2 receptors and serotonin 5-HT1A receptors, as well as potent antagonistic activity on serotonin 5-HT2A receptors. This drug stabilizes dopamine and serotonin activity in the limbic and cortical system. Aripiprazole is used in managing symptoms of schizophrenia and of acute manic and mixed episodes associated with bipolar I disorders.